| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
2,736,490,000 | 2,725,570,000 | 2,338,228,000 | 2,303,873,000 | 2,126,809,000 |
| Depreciation, Amortization and Depletion
|
-6,688,000 | -6,744,000 | -6,495,000 | -6,127,000 | -5,750,000 |
| Provision Expense/Write-Back
|
-- | -- | -- | -- | -- |
| Total Net Finance Income/Expense
|
-8,467,000 | -7,316,000 | -2,403,000 | -1,434,000 | -1,723,000 |
| Net Investment Income
|
-- | -- | -- | -- | -- |
| Irregular Income/Expenses
|
-24,516,000 | -22,374,000 | 2,604,000 | 7,440,000 | -101,000 |
|
Pretax Income
|
205,792,000 | 191,160,000 | 168,695,000 | 135,080,000 | -103,972,000 |
| Provision for Income Tax
|
-60,850,000 | -51,185,000 | -41,318,000 | -35,038,000 | -27,799,000 |
|
Net Income from Continuing Operations
|
144,942,000 | 139,975,000 | 127,377,000 | 100,042,000 | -131,771,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
144,941,000 | 139,974,000 | 127,377,000 | 100,041,000 | -131,771,000 |
|
Non-Controlling/Minority Interests
|
-1,007,000 | -1,006,000 | -992,000 | -1,264,000 | -378,000 |
|
Net Income after Non-Controlling/Minority Interests
|
143,935,000 | 138,968,000 | 126,384,000 | 98,777,000 | -132,150,000 |
|
Net Income Available to Common Stockholders
|
143,935,000 | 138,968,000 | 126,384,000 | 98,777,000 | -132,150,000 |
|
Diluted Net Income Available to Common Stockholders
|
143,935,000 | 138,968,000 | 126,384,000 | 98,777,000 | -132,150,000 |
| Basic EPS
|
294.44 | 279.64 | 241.67 | 183.13 | -237.31 |
| Diluted EPS
|
294.35 | 279.54 | 241.55 | 183.01 | -237.31 |
|
Basic Weighted Average Shares Outstanding
|
489,670.79 | 496,951.33 | 522,960.33 | 539,381.86 | 556,866.55 |
|
Diluted Weighted Average Shares Outstanding
|
489,828 | 497,131 | 523,220.87 | 539,735.53 | 559,773.26 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
214,259,000 | 198,476,000 | 171,098,000 | 136,514,000 | -102,249,000 |
|
EBITDA
|
220,947,000 | 221,818,000 | 192,984,000 | 157,541,000 | -81,065,000 |
|
Normalized EBITDA
|
243,742,000 | 244,192,000 | 190,135,000 | 149,862,000 | -81,085,000 |
|
Normalized Income
|
160,996,814.84 | 257,191,000 | 198,595,000 | 159,809,000 | -74,144,000 |
|
Total Unusual Items
|
22,795,000 | 22,374,000 | -2,849,000 | -7,679,000 | -20,000 |
|
Total Unusual Items Excluding Goodwill
|
22,795,000 | 22,374,000 | -2,849,000 | -7,679,000 | -20,000 |
|
Tax Effect of Unusual Items
|
6,740,185.17 | 5,990,862.24 | -698,005 | -1,988,861 | -4,640 |
|
Tax Rate, Calculated
|
0.30 | 0.27 | 0.24 | 0.26 | 0.23 |
3/31/2023 - 4/1/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade